All Stories

  1. Mesoporous silica-based nanocomposite surfaces with ROS-generating copper phosphonate functional groups in the fight against dangerous microorganisms
  2. A Patient-Derived Scaffold-Based 3D Culture Platform for Head and Neck Cancer: Preserving Tumor Heterogeneity for Personalized Drug Testing
  3. Analysis of Antifungal Drug Resistance Among Candida Spp. and Other Pathogenic Yeasts Isolated from Patients in Eastern Poland: Diagnostic Problems [Corrigendum]
  4. Advancing Head and Neck Cancer Therapies: From Conventional Treatments to Emerging Strategies
  5. Analysis of Antifungal Drug Resistance Among Candida Spp. and Other Pathogenic Yeasts Isolated from Patients in Eastern Poland: Diagnostic Problems
  6. Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
  7. Acetylation of Histone H3 in Cancer Progression and Prognosis
  8. Transcription Factors and Markers Related to Epithelial–Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers
  9. Cooperativity of ESPT and Aggregation-Induced Emission Effects—An Experimental and Theoretical Analysis of a 1,3,4-Thiadiazole Derivative
  10. Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine
  11. The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease
  12. Emodin-8-O-Glucoside—Isolation and the Screening of the Anticancer Potential against the Nervous System Tumors
  13. Heterogeneous Cellular Response of Primary and Metastatic Human Gastric Adenocarcinoma Cell Lines to Magnoflorine and Its Additive Interaction with Docetaxel
  14. Estrogen Receptor Signaling in Breast Cancer
  15. Kaiso Protein Expression Correlates with Overall Survival in TNBC Patients
  16. Dexmedetomidine Increases MMP-12 and MBP Concentrations after Coronary Artery Bypass Graft Surgery with Extracorporeal Circulation Anaesthesia without Impacting Cognitive Function: A Randomised Control Trial
  17. Zingiber officinale Rosc. in the Treatment of Metabolic Syndrome Disorders—A Review of In Vivo Studies
  18. Effect of Antibiotic Amphotericin B Combinations with Selected 1,3,4-Thiadiazole Derivatives on RPTECs in an In Vitro Model
  19. Isoquinoline Alkaloids from Coptis chinensis Franch: Focus on Coptisine as a Potential Therapeutic Candidate against Gastric Cancer Cells
  20. Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis
  21. Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells
  22. Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines
  23. Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models
  24. Valproic Acid and Breast Cancer: State of the Art in 2021
  25. Xanthohumol Impairs the PMA-Driven Invasive Behaviour of Lung Cancer Cell Line A549 and Exerts Anti-EMT Action
  26. Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together
  27. Epidermal Growth Factor Receptor and its OncogenicEGFRvIIIVariant in Benign and Malignant Brain Tumors
  28. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
  29. Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells
  30. Synthetic Betulin Derivatives Inhibit Growth of Glioma CellsIn Vitro
  31. Imperatorin as a Promising Chemotherapeutic Agent against Human Larynx Cancer and Rhabdomyosarcoma Cells
  32. Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin
  33. Prostate and breast cancer cells death induced by xanthohumol investigated with Fourier transform infrared spectroscopy
  34. Advances in Chemistry and Bioactivity of Magnoflorine and Magnoflorine-Containing Extracts
  35. Synthetic analogues of 2-oxo acids discriminate metabolic contribution of the 2-oxoglutarate and 2-oxoadipate dehydrogenases in mammalian cells and tissues
  36. Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients
  37. Xanthohumol exhibits anti-myeloma activity in vitro through inhibition of cell proliferation, induction of apoptosis via the ERK and JNK-dependent mechanism, and suppression of sIL-6R and VEGF production
  38. Genetical engineered lung cancer cell for analyzing Epithelial-Mesenchymal transition
  39. Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
  40. Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis
  41. MMP-9 and MMP-2 regulation in patients undergoing non-oncological and non-vascular elective surgery independent of the use of propofol or sevoflurane
  42. H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy
  43. Role of N-terminus in function and dynamics of sirtuin 7: an in silico study
  44. MMP-2 mRNA Expression in Ovarian Cancer Tissues Predicts Patients' Response to Platinum-Taxane Chemotherapy
  45. Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
  46. T-Lymphocyte Activation Is Correlated With the Presence of Anti-EBV in Patients With Laryngeal Squamous Cell Carcinoma
  47. AMPA Receptor Antagonist CFM-2 Decreases Survivin Expression in Cancer Cells
  48. Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins
  49. Mapping of the three-dimensional lymphatic microvasculature in bladder tumours using light-sheet microscopy
  50. Light-inducible systems can aid the speed and accuracy in drug discovery
  51. Superior anticancer activity is demonstrated by total extract ofCurcuma longaL. as opposed to individual curcuminoids separated by centrifugal partition chromatography
  52. Combination of Osthole and Cisplatin Against Rhabdomyosarcoma TE671 Cells Yielded Additive Pharmacologic Interaction by Means of Isobolographic Analysis
  53. Factors influencing P terminal force in lead V1 of the ECG in hemodialysis patients
  54. Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity
  55. Analysis of NPM1 splice variants reveals differential expression patterns of prognostic value in acute myeloid leukemia
  56. Cyclooxygenase-2 Inhibition Enhances Proliferation of NKT Cells Derived from Patients with Laryngeal Cancer
  57. Additive Interaction of Cisplatin and Histone Deacetylase Inhibitors Combined Treatment in Rhabdomyosarcoma Cells – Αn Isobolographic Analysis
  58. How to Train a Cell–Cutting-Edge Molecular Tools
  59. Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells
  60. Serum microtubule associated protein tau and myelin basic protein as the potential markers of brain ischaemia-reperfusion injury in patients undergoing carotid endarterectomy
  61. Serum glial fibrillary acidic protein as a marker of brain damage in patients after carotid endarterectomy
  62. Inhibition of mitochondrial 2-oxoglutarate dehydrogenase impairs viability of cancer cells in a cell-specific metabolism-dependent manner
  63. Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells
  64. Effect of carotid endarterectomy on brain damage markers
  65. A quick, one-step method for mutagenesis (additons, deletions or substitutions)
  66. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines – An Isobolographic Analysis
  67. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro
  68. Discovery of nitroaryl urea derivatives with antiproliferative properties
  69. Comprehensive Review on Betulin as a Potent Anticancer Agent
  70. Glutamate and its receptors in cancer
  71. MicroRNAs-Role in Lung Cancer
  72. Preliminary results of prognostic significance of proliferating cell nuclear antigen expression in advanced primary larynx carcinomas and lymph node metastases
  73. The role of ionotropic glutamate receptors in cancer biology
  74. Betulin Elicits Anti-Cancer Effects in Tumour Primary Cultures and Cell LinesIn Vitro
  75. Expression of glutamate receptor subunits in human cancers
  76. The role of matrix metalloproteinases in infant traumatic brain injury
  77. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells
  78. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth
  79. Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain
  80. Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood
  81. The Intermediate Filament Protein Keratin 8 Is a Novel Cytoplasmic Substrate for c-Jun N-terminal Kinase
  82. Tumor angiogenesis in patients with laryngeal cancer